Search Count: 7
 |
Crystal Structure Of The N-Terminal Domain Of Burkholderia Pseudomallei Antitoxin Hicb
Organism: Burkholderia pseudomallei k96243
Method: X-RAY DIFFRACTION Resolution:1.56 Å Release Date: 2018-10-31 Classification: ANTITOXIN |
 |
Organism: Burkholderia pseudomallei
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2018-10-31 Classification: ANTITOXIN Ligands: CL, GOL |
 |
Organism: Burkholderia pseudomallei k96243
Method: X-RAY DIFFRACTION Resolution:2.49 Å Release Date: 2018-10-31 Classification: ANTITOXIN Ligands: SO4, EDO, PGE |
 |
Ternary Complex Of E.Coli Leucyl-Trna Synthetase, Trna(Leu)574 And The Benzoxaborole An3017 In The Editing Conformation
Organism: Escherichia coli, Escherichia coli k-12
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2013-04-17 Classification: LIGASE/RNA Ligands: MG |
 |
Ternary Complex Of E .Coli Leucyl-Trna Synthetase, Trna(Leu) And The Benzoxaborole An3016 In The Editing Conformation
Organism: Escherichia coli, Escherichia coli k-12
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2013-04-17 Classification: LIGASE/RNA Ligands: MG |
 |
Ternary Complex Of E .Coli Leucyl-Trna Synthetase, Trna(Leu) And The Benzoxaborole An3213 In The Editing Conformation
Organism: Escherichia coli, Escherichia coli k-12
Method: X-RAY DIFFRACTION Resolution:2.31 Å Release Date: 2013-04-17 Classification: LIGASE/RNA |
 |
An Orally-Bioavailable Hiv-1 Protease Inhibitor Containing An Imidazole-Derived Peptide Bond Replacement. Crystallographic And Pharmacokinetic Analysis
Organism: Human immunodeficiency virus type 1 bh10
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 1994-10-15 Classification: HYDROLASE(ACID PROTEASE) Ligands: IM1 |